目标试验模拟的因果分析可消除真实世界证据中的大量自身偏倚:卵巢癌治疗有效性系统偏倚评估
本研究以进展期卵巢癌为例,回顾性比较接受与未接受二线化疗的总生存,采用从粗分析到含时变协变量的边际结构Cox模型模拟参考随机对照试验的逐步因果分析,将各方法效应估计与参考试验HR比较。参考试验二线治疗对比延迟治疗的HR为1.01(95%CI 0.82-1.25),真实世界数据分析HR从0.51(简单基线调整)到1.41(95%CI 1.22-1.64,处理不死时间偏倚),因果试验模拟HR为1.12(95%CI 0.96-1.28),提示充分因果设计对真实世界数据模拟临床试验结果的重要性。
要点
- 参考试验二线治疗对比延迟治疗HR为1.01(95%CI 0.82-1.25)。
- 真实世界数据分析HR从0.51到1.41(95%CI 1.22-1.64)。
- 因果试验模拟HR为1.12(95%CI 0.96-1.28),接近参考试验。
核心结论
- 以卵巢癌为例,若期望真实世界数据模拟临床试验结果,充分的因果设计与分析至关重要。
研究设计与样本
- 回顾性比较进展期卵巢癌接受与未接受二线化疗的总生存,数据来自电子病历。
- 使用有向无环图确定潜在偏倚,并采用从粗分析、多变量校正Cox模型到含时变协变量的边际结构Cox模型模拟参考随机对照试验的逐步因果分析。
主要发现
- 参考试验二线治疗对比延迟治疗的HR为1.01(95%CI 0.82-1.25)。
- 真实世界数据分析的HR从简单基线调整的0.51到处理不死时间偏倚的1.41(95%CI 1.22-1.64)。
- 因果试验模拟的HR为1.12(95%CI 0.96-1.28)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: Drawing causal conclusions from real-world data (RWD) poses methodological challenges and risk of bias. We aimed to systematically assess the type and impact of potential biases that may occur when analyzing RWD using the case of progressive ovarian cancer. METHODS: We retrospectively compared overall survival with and without second-line chemotherapy (LOT2) using electronic medical records. Potential biases were determined using directed acyclic graphs. We followed a stepwise analytic approach ranging from crude analysis and multivariable-adjusted Cox model up to a full causal analysis using a marginal structural Cox model with replicates emulating a reference randomized controlled trial (RCT). To assess biases, we compared effect estimates (hazard ratios [HRs]) of each approach to the HR of the reference trial. RESULTS: The reference trial showed an HR for second line vs. delayed therapy of 1.01 (95% confidence interval [95% CI]: 0.82-1.25). The corresponding HRs from the RWD analysis ranged from 0.51 for simple baseline adjustments to 1.41 (95% CI: 1.22-1.64) accounting for immortal time bias with time-varying covariates. Causal trial emulation yielded an HR of 1.12 (95% CI: 0.96-1.28). CONCLUSION: Our study, using ovarian cancer as an example, shows the importance of a thorough causal design and analysis if one is expecting RWD to emulate clinical trial results.
引用
- Kuehne F, Arvandi M, Hess LM, et al. Causal analyses with target trial emulation for real-world evidence removed large self-inflicted biases: systematic bias assessment of ovarian cancer treatment effectiveness. J Clin Epidemiol. 2022. PMID: 36252741. doi:10.1016/j.jclinepi.2022.10.005
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。